Seed treatment options are available to manage various fungi, insects, and nematodes that can damage soybeans before, during, and after emergence. These treatments are potentially beneficial for stand establishment and for protection against soybean cyst nematode (SCN). However, these seed treatments represent an additional cost to the producer.
A Comparison of Soybean Seed Treatments

RFR-A1189
Paul Kassel, Extension field agronomist David Rueber, farm superintendent Introduction Seed treatment options are available to manage various fungi, insects, and nematodes that can damage soybeans before, during, and after emergence. These treatments are potentially beneficial for stand establishment and for protection against soybean cyst nematode (SCN). However, these seed treatments represent an additional cost to the producer.
This study was initiated to compare the effects of a fungicide only treatment, a fungicideinsecticide-nematicide treatment, and an untreated control on SCN soil populations and grain yield.
Materials and Methods
Soybean variety Stine 19RA02 was planted May 11, 2011 at 152,000 seeds/acre. Each plot was four 30-in. rows wide and 50 ft long. The experimental area was corn in 2010.
Tillage, planting, and pest management operations were typical of soybean production practices in northern Iowa.
Treatment 1 is a combination of an insecticide, a nematicide, two fungicides, and a biological fungicide. Treatment 2 is a combination of two fungicides. The seed treatments were applied with commercial seed treatment equipment (Table 2) .
Each plot was sampled on June 28 and September 30 for beginning and ending soybean cyst nematode numbers per one-half cup of soil.
The plots were harvested on October 1, 2011. Soybean grain yield results are reported in Table 1 .
Results and Discussion
Treatment 1 had greater SCN eggs per half cup at the end of the growing season and a greater difference between early and late season assessments, despite including a nematicide.
There were no differences in grain yield between treatments in this study (P = 0.63). 
